Kaempferol
A dietary flavonol, a competitive FAAH inhibitor in vitro (Ki = 5 µM).
C₁₅H₁₀O₆
CAS 520-18-3
- Family
- ECS pharmacological toolEnzyme inhibitor
- Molar mass
- 286.24 g/mol
Updated on
In plain terms
Kaempferol is a plant pigment found in many vegetables and in tea. It does not come from hemp. In the laboratory, it slows the enzyme that destroys anandamide, the molecule the body makes itself, but at concentrations much higher than those measured in the blood after a meal.
Receptors and activity
Target network
- Blocks or inhibits
The lower the cited value, the closer the target sits to Kaempferol: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of Kaempferol.
FAAHFAAH found in 7 regions of the body
- CortexpresentCortical pyramidal neurons1
- Basal gangliapresentStriatal neurons1
- HypothalamuspresentPresent in hypothalamic nuclei1
- CerebellumpresentPurkinje cells and cerebellar layers1
- BrainstempresentInferior olivary nuclei1
- Adipose tissuepresentExpressed in mature adipocytes2
- BonepresentPresent on osteoclasts3
Map sources
- Romero J et al. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Brain Res Mol Brain Res, 2002 (new tab)
- Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes, 2005 (new tab)
- Rossi F et al. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone, 2009 (new tab)
Cited values
- FAAHInhibitorKi = 5 µM · rat22 out of 100
Thors et al. 2008, Br J Pharmacol (new tab) · hydrolysis of ethanolamine-labelled anandamide, rat brain homogenates; competitive inhibition
Measured effects
Not characterised. No placebo-controlled human trial has measured the effects of Kaempferol, so no level is shown.
Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method
Pharmacology
Kaempferol is a common dietary flavonol whose endocannabinoid interest lies in an indirect mechanism. Its affinity for the CB1 and CB2 receptors was not measured in the reference study: it acts on FAAH, the enzyme that hydrolyses anandamide. In 2008, Thors, Belghiti and Fowler tested twenty compounds and found it the most potent of the widely distributed flavonoids, with competitive inhibition and a Ki of 5 µM in rat brain homogenates; two flavonoids of more restricted distribution were more active, 7-hydroxyflavone (IC50 of 0.5 to 1 µM depending on the solvent) and 3,7-dihydroxyflavone (IC50 = 2.2 µM). All three compounds reduced FAAH-dependent anandamide uptake and metabolism in intact RBL2H3 cells. This work extends that on the isoflavones genistein and daidzein (Thors 2007). The physiological relevance is limited: after an endive meal providing 9 mg of kaempferol, the mean plasma peak was 0.1 µM (DuPont 2004), and the authors consider FAAH inhibition by dietary flavonoids unlikely; they propose these compounds as chemical templates for designing inhibitors.
Key sources.
- Thors, Belghiti & Fowler 2008, Br J Pharmacol: FAAH inhibition by kaempferol and related flavonoids (new tab)PMID 18552875
- Thors et al. 2007, Br J Pharmacol: genistein, daidzein and anandamide uptake (new tab)PMID 17676056
- DuPont et al. 2004, Eur J Clin Nutr: absorption of kaempferol from endive in humans (new tab)PMID 15164116
History
- Source
- A flavonol very widespread in the plant kingdom, including in vegetables and tea, most often as glycosides or glucuronides; endive, for example, contains it as kaempferol-3-glucuronide (DuPont 2004). It is not produced by cannabis.
Origin
Research tool
A flavonol from the phenylpropanoid pathway: coumaroyl-coenzyme A condenses with three malonyl-coenzyme A units under the action of chalcone synthase; the chalcone is cyclised to a flavanone, then hydroxylated and desaturated to the flavonol. This pathway has no connection with the biosynthesis of hemp cannabinoids.
Legal framework
- European Union
No European Union instrument and no schedule of the 1961 and 1971 United Nations conventions covers kaempferol, a natural food constituent. A highly concentrated extract intended for supplementation would fall under EU food law, including, where applicable, Regulation (EU) 2015/2283 on novel foods.
- France
Not classified as a narcotic in France: a plant flavonol without a cannabinoid skeleton, kaempferol is named in no schedule of the arrêté of 22 February 1990 and does not fall within the generic class of the benzo[c]chromene nucleus (ANSM decisions of 2024). A constituent of the ordinary diet, it falls under food law.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
ECS pharmacological tool › Enzyme inhibitor
- Verification
Every fact on this entry was checked against its primary sources on 20 October 2026.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Thors, Belghiti & Fowler 2008, Br J Pharmacol: FAAH inhibition by kaempferol and related flavonoids (new tab)PMID 18552875
- Thors et al. 2007, Br J Pharmacol: genistein, daidzein and anandamide uptake (new tab)PMID 17676056
- DuPont et al. 2004, Eur J Clin Nutr: absorption of kaempferol from endive in humans (new tab)PMID 15164116
Identifiers
Names
- IUPAC name
- 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one
- Other names
- campherol · robigenin
Identifiers
- Formula
- C₁₅H₁₀O₆
- CAS
- 520-18-3
- PubChem CID
- 5280863(new tab)
- InChIKey
- IYRMWMYZSQPJKC-UHFFFAOYSA-N
- SMILES
- C1=
CC(= CC= C1C2= C(C(= O) C3= C(C= C(C= C3O2) O) O) O) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.